SonoThera

About:

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.

Top Investors: ARCH Venture Partners, Alexandria Venture Investments, Johnson & Johnson Innovation – JJDC, Foothill Ventures, Eli Lilly & Company Foundation

Description:

SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease. SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. It aims to improve the lives and health of millions of people.

Total Funding Amount:

$60.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)sonothera.com

Founders:

Kenneth Greenberg, Michael Davidson, Steve Feinstein

Number of Employees:

11-50

Last Funding Date:

2022-12-05

IPO Status:

Private

Industries: